NKTR Nektar Therapeutics

HealthcareBiotechnology
$83.37
▼ 2.02%
35
QScore Signal
Short
Confidence: MEDIUM
Long-Term
22
Short-Term
48

Value

11
P/E-10.31
8
P/B18.84
35
P/S30.64
0
EV/EBITDA-14.85
5

Growth

26
Revenue Growth-43.9%
0
EPS Growth-12.1%
42
FCF Growth-17.8%
42

Momentum

82
12-Month Return765.7%
100
3-Month Return137.4%
100
1-Month Return11.0%
73
RSI (14)48.25
50
50/200 MABullish
75

Profitability

11
ROE-399.1%
0
ROA-58.5%
0
Gross Margin99.6%
78
Operating Margin-237.9%
0
Net Margin-297.1%
0
FCF Yield-12.3%
0

Risk

34
Beta1.25
75
60-Day Volatility71.2%
0

Generated 5/7/2026, 9:21:08 PM · How is this calculated?

QScore Analysis